Article
Apixaban, an orally available anticoagulant, inhibits SARS-CoV-2 replication and its major protease in a non-competitive way
Registro en:
CHAVES, Otávio Augusto et al. Apixaban, an orally available anticoagulant, inhibits SARS-CoV-2 replication and its major protease in a non-competitive way. Journal of Molecular Cell Biology, v. 14, n. 6, p. 1-4, June 27 2022.
1759-4685
10.1093/jmcb/mjac039
Autor
Chaves, Otávio Augusto
Sacramento, Carolina Q.
Fintelman-Rodrigues, Natalia
Temerozo, Jairo Ramos
Dutra, Filipe Pereira
Mizurini, Daniella M.
Monteiro, Robson Q.
Vazquez, Leonardo
Bozza, Patrícia Torres
Faria Neto, Hugo Caire Castro
Souza, Thiago Moreno L.